SDCBP and metastatic malignant neoplasm in the lymph nodes: On the other hand, there is a quantitative interaction between lymph node metastasis and syntenin-1 expression (in the high expression group, N1 had 13 survivors (50.00%) and 13 deaths (50.00%), while in the low expression group, N1 survived 41 (97.62%) and died 1 (2.38%)), indicating that the high expression group of patients with lymph node metastasis has a strong poor prognosis.